FDA Application
-
NDC Search Results on Active Ingredient: Diclofenac
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
DICLOFENAC SODIUM | 0010-4498-01 | Boehringer Ingelheim Animal Health USA Inc. | NADA141186 | PRESCRIPTION ANIMAL DRUG | NADA |
DICLOFENAC SODIUM; MISOPROSTOL | 0025-1411-60 | Pfizer Laboratories Div Pfizer Inc | NDA020607 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC SODIUM; MISOPROSTOL | 0025-1411-90 | Pfizer Laboratories Div Pfizer Inc | NDA020607 | HUMAN PRESCRIPTION DRUG | NDA |
MISOPROSTOL; DICLOFENAC SODIUM | 0025-1421-60 | Pfizer Laboratories Div Pfizer Inc | NDA020607 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC SODIUM | 0067-8152-01 | Haleon US Holdings LLC | NDA022122 | HUMAN OTC DRUG | NDA |
DICLOFENAC SODIUM | 0067-8152-02 | Haleon US Holdings LLC | NDA022122 | HUMAN OTC DRUG | NDA |
DICLOFENAC SODIUM | 0067-8152-03 | Haleon US Holdings LLC | NDA022122 | HUMAN OTC DRUG | NDA |
DICLOFENAC SODIUM | 0067-8152-04 | Haleon US Holdings LLC | NDA022122 | HUMAN OTC DRUG | NDA |
DICLOFENAC SODIUM | 0067-8152-05 | Haleon US Holdings LLC | NDA022122 | HUMAN OTC DRUG | NDA |
DICLOFENAC SODIUM | 0067-8152-08 | Haleon US Holdings LLC | NDA022122 | HUMAN OTC DRUG | NDA |
DICLOFENAC SODIUM | 0067-8152-09 | Haleon US Holdings LLC | NDA022122 | HUMAN OTC DRUG | NDA |
DICLOFENAC SODIUM | 0067-8153-01 | Haleon US Holdings LLC | NDA022122 | HUMAN OTC DRUG | NDA |
DICLOFENAC SODIUM | 0078-0478-61 | Novartis Pharmaceutical Corporation | NDA020037 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC POTASSIUM | 0093-0948-01 | Teva Pharmaceuticals USA, Inc. | ANDA075219 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC POTASSIUM | 0093-0948-05 | Teva Pharmaceuticals USA, Inc. | ANDA075219 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC EPOLAMINE | 0093-3727-50 | Teva Pharmaceuticals USA Inc. | NDA021234 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
DICLOFENAC EPOLAMINE | 0093-3727-55 | Teva Pharmaceuticals USA Inc. | NDA021234 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
DICLOFENAC SODIUM | 0113-1189-01 | L. Perrigo Company | ANDA211253 | HUMAN OTC DRUG | ANDA |
DICLOFENAC SODIUM | 0113-1189-03 | L. Perrigo Company | ANDA211253 | HUMAN OTC DRUG | ANDA |
DICLOFENAC SODIUM | 0228-2550-06 | Actavis Pharma, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 0228-2550-11 | Actavis Pharma, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 0228-2550-96 | Actavis Pharma, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 0228-2551-06 | Actavis Pharma, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 0228-2551-11 | Actavis Pharma, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 0228-2551-96 | Actavis Pharma, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 0280-0039-01 | Bayer HealthCare LLC | ANDA211253 | HUMAN OTC DRUG | ANDA |
DICLOFENAC SODIUM | 0280-0039-02 | Bayer HealthCare LLC | ANDA211253 | HUMAN OTC DRUG | ANDA |
DICLOFENAC SODIUM | 0363-1210-17 | Walgreens | ANDA208077 | HUMAN OTC DRUG | ANDA |
DICLOFENAC SODIUM | 0363-1210-35 | Walgreens | ANDA208077 | HUMAN OTC DRUG | ANDA |
DICLOFENAC SODIUM | 0363-1210-53 | Walgreens | ANDA208077 | HUMAN OTC DRUG | ANDA |
-